First Time Loading...

Sutro Biopharma Inc
NASDAQ:STRO

Watchlist Manager
Sutro Biopharma Inc Logo
Sutro Biopharma Inc
NASDAQ:STRO
Watchlist
Price: 3.74 USD 10.16% Market Closed
Updated: May 2, 2024

Sutro Biopharma Inc
Revenue

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Sutro Biopharma Inc
Revenue Peer Comparison

Comparables:
ABBV
GILD
AMGN
VRTX
REGN

Competitive Revenue Analysis
Latest Figures & CAGR of Competitors

Company Revenue CAGR 3Y CAGR 5Y CAGR 10Y
Sutro Biopharma Inc
NASDAQ:STRO
Revenue
$153.7m
CAGR 3-Years
53%
CAGR 5-Years
32%
CAGR 10-Years
N/A
Abbvie Inc
NYSE:ABBV
Revenue
$54.3B
CAGR 3-Years
6%
CAGR 5-Years
11%
CAGR 10-Years
11%
Gilead Sciences Inc
NASDAQ:GILD
Revenue
$27.1B
CAGR 3-Years
3%
CAGR 5-Years
4%
CAGR 10-Years
9%
Amgen Inc
NASDAQ:AMGN
Revenue
$28.2B
CAGR 3-Years
4%
CAGR 5-Years
3%
CAGR 10-Years
4%
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
Revenue
$9.9B
CAGR 3-Years
17%
CAGR 5-Years
26%
CAGR 10-Years
23%
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
Revenue
$13.1B
CAGR 3-Years
16%
CAGR 5-Years
14%
CAGR 10-Years
20%

See Also

What is Sutro Biopharma Inc's Revenue?
Revenue
153.7m USD

Based on the financial report for Dec 31, 2023, Sutro Biopharma Inc's Revenue amounts to 153.7m USD.

What is Sutro Biopharma Inc's Revenue growth rate?
Revenue CAGR 5Y
32%

Over the last year, the Revenue growth was 127%. The average annual Revenue growth rates for Sutro Biopharma Inc have been 53% over the past three years , 32% over the past five years .